Popular Posts

This ‘living drug’ could change the course of autoimmune disease




If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News